Development of cardiac sympathetic and adrenal-medullary responses in borderline hypertensive rats.
Borderline hypertensive (BHR) rats are the first generation offspring of a cross of spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) normotensive rats. In adulthood, BHRs have systolic blood pressures in the 140-160 mm Hg range. If subjected to chronic stress paradigms, however, BHRs develop sustained and permanent elevations in systolic blood pressure (180-200 mm Hg). In the present study, we examined the functional development of cardiac and adrenal medullary responses to reflex activation of the sympathetic nervous system in preweanling BHR and WKY rats. Pups of the two groups were injected with insulin or saline at 4, 8, 12, or 16 days of age and sacrificed 3 h later. Insulin produces an acute lowering of blood glucose which is attended by a centrally mediated increase in sympathetic activity. The induction of ornithine decarboxylase (ODC) activity in heart and the depletion of epinephrine from the adrenal medulla were biochemical indicators of functional sympathetic neurotransmission. WKY and BHR pups had similar levels of cardiac ODC activity under basal conditions and following administration of insulin. In contrast, BHRs had higher amounts of adrenal norepinephrine and epinephrine from 4 to 16 days of age and greater depletion of adrenal epinephrine following insulin administration at 8, 12 and 16 days of age. These findings indicate that BHRs have a greater capacity for catecholamine biosynthesis, storage and release in the adrenal medulla during the preweanling period compared to age-matched normotensive WKY controls. This alteration in the adrenal medulla during the preweanling period may contribute to the susceptibility of adult BHR rats to stress-induced hypertension.
McCarty
R
R
Department of Psychology, University of Virginia, Charlottesville 22903.
Cierpial
M A
MA
Kirby
R F
RF
Jenal
T J
TJ
D000313:Adrenal Medulla / Q000187:drug effects / Q000254:growth & development*; D000375:Aging; D000818:Animals; D004790:Enzyme Induction; D004837:Epinephrine / Q000378:metabolism; D005260:Female; D006321:Heart / Q000187:drug effects / Q000254:growth & development*; D006329:Heart Conduction System / Q000254:growth & development*; D006973:Hypertension / Q000503:physiopathology*; D007328:Insulin / Q000494:pharmacology; D008297:Male; D009638:Norepinephrine / Q000378:metabolism; D009929:Organ Size / Q000187:drug effects; D009955:Ornithine Decarboxylase / Q000096:biosynthesis; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D013564:Sympathetic Nervous System / Q000254:growth & development*
D007328:Insulin; D009955:Ornithine Decarboxylase; D009638:Norepinephrine; D004837:Epinephrine